Author of the publication

A scoping review of the pathophysiology of COVID-19

, , , and . International Journal of Immunopathology and Pharmacology, (January 2021)
DOI: 10.1177/20587384211048026

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Strictly regular use of ivermectin as prophylaxis for COVID-19 leads to a 90\% reduction in COVID-19 mortality rate, in a dose-response manner: definitive results of a prospective observational study of a strictly controlled 223,128 population from a city-wide program in Southern Brazil., , , , , , , , and . Research Gate, (2022)MATH+ protocol for the treatment of SARS-CoV-2 infection: the scientific rationale, , , , and . Expert Review of Anti-infective Therapy, 0 (0): 1-7 (2020)Clinical and Scientific Rationale for the “MATH$\mathplus$” Hospital Treatment Protocol for COVID-19, , , , and . Journal of Intensive Care Medicine, (December 2020)A scoping review of the pathophysiology of COVID-19, , , and . International Journal of Immunopathology and Pharmacology, (January 2021)Informational Needs During Intensive Care Unit Handovers: A Multicenter Study., , , , , , and . AMIA, AMIA, (2014)Regular use of ivermectin as prophylaxis for COVID-19 led up to 92% reduction in COVID-19 mortality rate in a dose-response manner: results of a prospective observational study of a strictly controlled population of 88,012 subjects among 223,128 participants, , , , , , , and . Research Gate, (2022)Regular Use of Ivermectin as Prophylaxis for COVID-19 Led Up to a 92\% Reduction in COVID-19 Mortality Rate in a Dose-Response Manner: Results of a Prospective Observational Study of a Strictly Controlled Population of 88,012 Subjects, , , , , , , , and . Cureus, (August 2022)Effective post-exposure prophylaxis of Covid-19 is associated with use of hydroxychloroquine: Prospective re-analysis of a public dataset incorporating novel data., , , and . (December 2020)Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching, , , , , , , , and . Cureus, 14 (1): e21272 (January 2022)